InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Barrage Khalil, Director. Director active across 1 company, notably Protagenic Therapeutics, Inc.\new. Aggregated, 1 filings have been logged. History available since 3 May 2021. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Khalil Barrage is a Board Member at Protagenic Therapeutics, Inc. He contributes to the governance of the company, bringing his expertise in strategy and leadership. His role is essential for guiding strategic decisions and ensuring compliance with industry standards.